Since chronic congestive heart failure syndromes are associated with both elevated circulating levels of angiotensin II and potentially lethal ventricular tachyarrhythmias, we investigated the effect of angiotensin II on voltage-dependent cardiac Na + currents. Single-channel Na + currents in neonatal rat ventricular myocytes were studied using the patch clamp method in the cell-attached mode. Angiotensin II applied outside the patch increased the frequency of opening and rates of activation and inactivation of single-channel Na + currents within the patch. These effects were mimicked by the phorbol ester 12 -O-tetradecanoylphorbol-13 -acetate (TPA) and were prevented by prior incubation with TPA. Therefore, we propose that angiotensin II modulates cardiac Na + currents by a cytoplasmic second messenger, perhaps protein kinase C, and this may predispose toward arrhythmia. (Circulation Research 1989;65:1804- ; 2) Ang II increases phosphoinositide production in heart 5 -7 and other tissues, and increases levels of diacylglycerol, the physiological activator of protein kinase C (PKC); 3) PKC activators stimulate cardiac Ca 2+ channels 8 and K + channels, 9 and PKC phosphorylates brain Na + channels 10 ; and 4) phosphorylation of Na + channels by cyclic AMP-dependent protein kinase (PKA) alters inactivation gating. 10 Therefore, we tested the effects of Ang II and the PKC activating phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA) on voltage-dependent Na + currents of neonatal rat ventricular myocytes grown in primary tissue culture.
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Materials and Methods
Neonatal rat ventricular myocytes were studied 12 to 36 hours after isolation 11 using cell-attached gigaohm seals. 12 The bath solution contained K-aspartate 145 mM, MgCl 2 2 mM, and HEPES 10 mM (pH 7.35) and was selected to depolarize the cells to near 0 mV. EGTA (10 mM) was present in some experiments and did not affect results. The pipette solution contained NaCl 145 mM, KC1 2 mM, CaCl 2 1.8 mM, and HEPES 10 mM (pH 7.35). The holding potential was -100 mV, and 25-or 55-msec test pulses were preceded by 100-200-msec prepulses to -140 mV to circumvent the previously described hyperpolarizing shift in inactivation in cell-attached patches. 13 Pulse frequency was 0.5 Hz. The number of channels in each patch was estimated from the maximum number of overlapping events in five to 10 steps to a test potential of -20 mV. For measurements of membrane potentials, the K + -aspartate solution was used both in the bath and the pipette, and cell-attached gigaohm seals were made. The seals were then ruptured by extra suction, the pipette current clamped at 0, and the pipette potentials measured. Drugs were dissolved in the extracellular solution and were applied directly to the bath. Phorbol ester compounds were kept as stock solutions in dimethylsulfoxide, with final solvent concentrations <1% in all experiments. The temperature was 22° C in all but one experiment. The analog signal was filtered at 10 kHz (four-pole Bessel, -3 dB) and digitized at 44 kHz onto videotape. Before analysis, the signal was digitized offline at 2-5 kHz, then filtered digitally (four-pole Bessel) at 1 kHz (-3 dB). The method for idealization and analysis of single-channel events has been described previously. 13 
Results
Ang II had no effect on whole cell currents in well-dialyzed (pipette resistance, 0.5-1 Mil) cells. This result was anticipated based on our previous experience 8 showing that TPA effects on cardiac Ca 2+ channels were abolished by the whole-cell patch-clamp method but were present in the cellattached mode.
In our solutions, the single-channel currents were inwards at a test potential of -50 mV, were inactivated at holding potentials more positive than -60 mV, had a conductance of about 15 pS, and at a test potential of -50 mV, had a mean open time of 1-2 msee-and-unitary current amplitude of about 1.5 pA. These characteristics are typical Of cardiac Na + channels. 13 The ensemble average of the singlechannel currents had activation and inactivation waveforms that were also typical of cardiac Na + currents. 13 The only current with any similarities would be the low-voltage-activated or T-type Ca 2+ current. However, T channels do not conduct Na + ions in the presence of Ca 2+ at millimolar concentrations, and the single channel Ca 2+ current amplitudes would be far smaller in our external solutions.
14 Near threshold potentials, Ang II at 2 /JM applied to the cell outside the patch increased the peak probability of channel opening and decreased the number of reopenings, resulting in an increase and a mor& rapid decay of the ensemble average currents ( Figure 1 ). Under control conditions (A), channel openings at test potential -50 mV were dispersed throughout the 25-msec traces, and the average current (Bl) decayed with a time constant of 7.5 msec. After Ang II at 2 ^M (B2 and C), channel openings appeared mainly in the initial half of the trace, and the average number of openings in the second half of the trace fell from 2.8 to 0.9. The peak average current was larger (B2 vs. Bl, 1.48 vs. 0.66 pA, averages of 90 and 100 traces) and decayed more quickly (time constant, 4 msec).
Since Ang II produces hydrolysis of cardiac phosphoinositides, 5 -7 and since brain Na + channels can be phosphorylated by PKC, 10 the possibility of PKC activation was examined. TPA, a phorbol ester which activates PKC directly, at 200-nMiiad similar effects to Ang II ( Figure 1D-1F ). The peak current (El and E2, average of 90 traces each) increased from 0.84 to 2.01 pA, and the decay time constant decreased from 9 to 3 msec. The diacylglycerol analogue 1,2-dioctanoylglycerol, which also activates PKC directly, increased peak average current and the rate of current decay (2 fiM, n=2) while 4o-phorbol, a phorbol ester that does not activate PKC, had no effect on peak current or decay time constant (100 nM, «=4).
The lifetime of cell-attached patches was usually 15 minutes or less, so we used Ang II at concentrations nominally as high as 100 /AM to establish effects within 1-2 minutes. Since the peptide is readily hydrolyzed to an inactive form 3 and since functional stimulatory effects on cardiac Ca z+ chan- nels may not be observed in the absence of bovine serum albumin (A.E. Lacerda and D. Rampe, unpublished data), the effective concentration was much less than the nominal concentration. Effects were clearly evident at nominal concentrations of 250 nM (n=2), a level corresponding to saturation of high affinity Ang II binding to guinea pig ventricular membranes.
8 Figure 2A shows the effect of 250 nM to 100 (tM Ang II on a normalized peak current-voltage relation for four patches containing seven to 20 channels each. Peak currents were measured from the average of 15-20 traces at each potential. Control currents were normalized to the largest control value for each patch, and the Ang II currents were normalized to the largest Ang II value for each patch. Ang II increased Na + current most dramatically at test potentials from -60 to -40 mV. At larger depolarizations, the effect was much less apparent. The decrease in decay time constant was similarly more pronounced near threshold potentials in the few patches with currents large enough at multiple potentials for this analysis ( Figure 2B ).
The mechanism of the increase in current was an increase in the frequency of openings at the beginning of the depolarizing voltage step and a decrease in the latency to first opening ( Figure 3B ). As previously noted, 13 control data were fit best with a sum of two exponentials model. Here, the time constants were 1.3 msec (accounting for 50 of the 90 traces) and 30 msec, with an arithmetic mean of 3.3 msec. In Ang II at 100 ^M, the slow component was eliminated, and all 42 traces were accounted for by a time constant of 1.3 msec.
Unitary current amplitude was not affected. Figure 3A shows amplitude histograms from the same patch as Figures 1A-1C . The average of 636 openings in 90 control traces was 1.56 pA; the average of 516 openings in 100 traces with Ang II was 1.60 pA. Standard deviation was greater in control, but the mean amplitudes are not significantly different.
Pooled data from control («=8), Ang II (n = 14), and TPA («=8) experiments are shown in Figure  3C . Parameters measured in the first 3 minutes of data recording were compared with the same parameters during the final 3 minutes of recording, and the percent changes are recorded. Changes in peak amplitude of the average current could be determined in all experiments. Changes in decay T (time constant of the decay of the average current) could be accurately estimated only in patches containing more than six or seven channels, and single-channel kinetics could be accurately assessed only in patches containing three or fewer channels. Waiting time here denotes the arithmetic mean of the times from the beginning of each depolarizing pulse to the appearance of the first channel opening. The test potentials were -50 or -60 mV.
Patches were allowed to stabilize at a holding potential of -100 mV for 1-2 minutes to remove slow inactivation before recording data. Recordings from eight patches in control condition for another 8-20 minutes, the usual time span of the Ang II and TPA experiments, showed no significant change in average current amplitude or kinetics from the initial to the final 3-minute segments of the recordings ( Figure 3Q . In two control patches, peak average current increased 25% and 50% (the latter transiently) after the first 3 minutes. One of these patches also showed a 50% increase in the rate of current decay. Because gating of cardiac single-channel Na + currents is shifted to more negative potentials in excised inside-out patches, 13 we were careful to ensure that the patch pipette was cell-attached throughout the experiment. To verify this, we moved the pipette away from the cell at the end of the experiment and completely excised the patch; this produced changes in amplitude of the average current due to shifts in gating. 13 In addition, there were often changes in cell shape during this maneuver. Only patches that were clearly cell-attached throughout the experiment were analyzed. Since small depolarizations of resting potential of the cell could account for our findings, we confirmed ihat cell membrane potential was near 0 mV in our control solution (n=10), in 500 nM Ang II (n=6), and in 500 nM TPA (n=3). The membrane potential measured 0.7±2.4 mV (range, -1 to 8 mV), and no depolarization was seen with addition of test solutions.
To _tesj^ further the hypothesis that Ang II was acting as an activator of PKC^jye jncubated the myocytes for 2-3 hours in TPA at 200 nM (<0.1% dimethylsulfoxide solvent) or 4«-phorbol at 100 nM (<1% solvent) for 2-3 hours. This intervention is known to reduce the level of PKC available in the cell.
ls After washing with culture medium every 30-60 minutes for 2-5 hours, we assayed the effect of 100 yM Ang II. Pretreatment with TPA but not 4a-phorbol blocked the response to Ang n at 100 jiM (Figures 4A and 4B; n=4 each) . In separate experiments, the magnitude of whole cell Na + currents was the same in both groups of cells (range, 1-2 nA, n=3), and the opening probability of single channels before Ang II did not differ greatly ( Figure 4C ).
Discussion
Our most important finding in this study is that Ang II increases cardiac sodium channel activity, especially near threshold potentials. The critical aspect of our experimental technique was the use of cell-attached patch-clamp recordings. With this technique, gigaohm seals are made on patches of membrane that are still in continuity with the rest of the cell, 12 and the disruption of cellular processes that occurs with_whole-cell clamping is avoided. From our results on cell -attached patches, we conclude that Ang II modulates cardiac Na + currents, and a cytoplasmic second messenger must be involved because the Ang II was not applied directly to the affected Na + channels. We show preliminary evidence that the second messenger may be protein kinase C. The Ang II effect was mimicked by the direct PKC activating phorbol ester TPA and dioctanoylglycerol but not by the inactive phorbol ester 4a-phorbol. In addition, the Ang II effect was blocked by prior incubation in TPA. This observation is consistent with down-regulation of PKC by TPA and also points to a role for PKC as the mediator of the Ang II effect on cardiac Na + currents. Other explanations of this data are possible. Were Ang II receptor number decreased by TPA incubation, for example, the experimental results would have been the same. Proof that phosphorylation of the cardiac Na + channel protein by PKC underlies the observed effects of Ang II awaits a series of studies of the effects of purified PKC isoforms, PKC inhibitors, and protein phosphatases.
Ang II enhanced activation of Na + currents, possibly by shifting the activation gating to more negative potentials, but we did not examine the effect on resting inactivation. In our experiments, resting inactivation was removed at the holding and prepulse potentials.
Our findings are in agreement with other observations that phorbol ester activation of PKC may change Na + currents. Increased action potential upstroke velocity was reported after injection of phorbol ester of PKC into cat spinal motoneurons, 16 and phorbol esters have been reported to decrease Na + currents produced by injecting Xenopus oocytes with brain total messenger RNA. 17 The results are also consistent with the reports that activation of cyclic AMP-dependent protein kinase modulates neuronal 10 and cardiac 18 - 19 Na + currents. Our findings are likely to have clinical significance; elevated Ang II levels might, by stimulating cardiac Na + currents in cells near threshold potentials, be arrhythmogenic.
